SERPINB3 and squamous cell lung carcinoma: In addition, this study only initially explored the effect of camrelizumab combined with first-line chemotherapy on serum SCC, VEGF levels, and adverse reactions in patients with advanced lung squamous cell carcinoma, and further experiments will be conducted to explore its specific treatment mechanism in the later stage.